COIOSDeep risk insights through multi-disciplinary research across the globe
a tree in front of a building on a city street
Item new Preprint · not peer-reviewed Added

Canada's 2025/26 influenza vaccine cut A(H3N2) illness by 38%

In Canada's sentinel outpatient network, the 2025/26 vaccine cut the risk of A(H3N2) illness by 38%, even though most circulating viruses differed from the vaccine strain in laboratory tests.

The Canadian Sentinel Practitioner Surveillance Network tested outpatients with acute respiratory illness in 2025/26, sequencing the viruses found and comparing them with the vaccine strains. Vaccination cut the risk of A(H3N2) illness by 38%, although laboratory tests showed the dominant viruses were a poor match to the vaccine strain. Protection was 28% against A(H1N1)pdm09, which laboratory tests judged a good match, and 55% against influenza B overall.

Why it is interesting: Laboratory tests of strain match predicted actual protection poorly, in both directions, across this season.

Source
medRxiv, 12 September 2026
Paper
2025/26 subclade-specific influenza A and B vaccine effectiveness estimates and discordant laboratory-based indicators of vaccine match or mismatch
Authors
Separovic L, Kaweski SE, Cox MB, Zhan Y, Sabaiduc S, Olsha R et al.
DOI
10.64898/2026.09.10.26362769
Type
Preprint
Design
Test-negative design among outpatients with acute respiratory illness, 9,047 specimens sequenced and antigenically characterised, 2025/26 season
Verdict
New finding
Driver
Infection and pandemics

Other drivers in Behavioural science